Aripiprazole - Bipolar disorder (adults)
You are here : Home > Formulary Search > Aripiprazole - Bipolar disorder (adults)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Oral solution
- Oro-dispersible tablets
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Oro-dispersible tablets are more cost effective than oral solution. Reserve oral solution for use in patients where the required dose is not available in an oro-dispersible form.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Aripiprazole
Indication :
Bipolar disorder (adults)
Group Name :
Keywords :
manic episodes, mania, antipsychotics
Brand Names Include :
Abilify
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Committee Recommendations (1)
GENERIC Aripiprazole has been considered by the PCN and has been assigned a BLUE traffic light status.
NOTE - the branded product, Abilify, was considered BLACK at the PCN in May 2017.
NOTE - the branded product, Abilify, was considered BLACK at the PCN in May 2017.
Other Indications
Below are listed other indications that Aripiprazole is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Bipolar disorder (adults).